Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly A Workowski

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
MMWR. Morbidity and Mortality Weekly Report|December 17, 2020
Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020Sancta St Cyr, Lindley Barbee, Kimberly A Workowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2011
Trichomonas vaginalis genital infections: progress and challengesLaura H Bachmann, Marcia M Hobbs, Arlene C Seña, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2022
Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment GuidelinesPatricia J Kissinger, Charlotte A Gaydos, Arlene C Seña, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|July 22, 2021
Sexually Transmitted Infections Treatment Guidelines, 2021Kimberly A Workowski, Laura H Bachmann, Philip A Chan, et al.
Journal of Virology|August 1, 2008
Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infectionHenry Radziewicz, Chris C Ibegbu, Huiming Hon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 27, 2010
Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signalingHenry Radziewicz, Chris C Ibegbu, Huiming Hon, et al.
Sexually Transmitted Diseases|April 17, 2012
Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinicsKaren W Hoover, Mary Butler, Kimberly A Workowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose EvaluationStephanie N Taylor, David H Morris, Ann K Avery, et al.
Lancet (London, England)|April 17, 2025
Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre studyJonathan D C Ross, Janet Wilson, Kimberly A Workowski, et al.
Emerging Infectious Diseases|May 22, 2012
Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010Robert D Kirkcaldy, Peter Augostini, Lenore E Asbel, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
MMWR. Morbidity and Mortality Weekly Report|December 17, 2020
Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020Sancta St Cyr, Lindley Barbee, Kimberly A Workowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2011
Trichomonas vaginalis genital infections: progress and challengesLaura H Bachmann, Marcia M Hobbs, Arlene C Seña, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2022
Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment GuidelinesPatricia J Kissinger, Charlotte A Gaydos, Arlene C Seña, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|July 22, 2021
Sexually Transmitted Infections Treatment Guidelines, 2021Kimberly A Workowski, Laura H Bachmann, Philip A Chan, et al.
Journal of Virology|August 1, 2008
Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infectionHenry Radziewicz, Chris C Ibegbu, Huiming Hon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 27, 2010
Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signalingHenry Radziewicz, Chris C Ibegbu, Huiming Hon, et al.
Sexually Transmitted Diseases|April 17, 2012
Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinicsKaren W Hoover, Mary Butler, Kimberly A Workowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose EvaluationStephanie N Taylor, David H Morris, Ann K Avery, et al.
Lancet (London, England)|April 17, 2025
Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre studyJonathan D C Ross, Janet Wilson, Kimberly A Workowski, et al.
Emerging Infectious Diseases|May 22, 2012
Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010Robert D Kirkcaldy, Peter Augostini, Lenore E Asbel, et al.
Pageof 8